Baixar PDF

Outros usuários também visualizaram estes artigos

Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients Juan Caro-Codón, Juan R. Rey, Angel M. Iniesta, Sandra O. Rosillo, Sergio Castrejon-Castrejon, Laura Rodriguez-Sotelo, Jose M. Garcia-Veas, Irene Marco, Luis A. Martinez, Lorena Martin-Polo, Carlos Merino, Marcel Martinez-Cossiani, Antonio Buño, Luis Gonzalez-Valle, Alicia Herrero, Esteban López-de-Sá, Jose L. Merino
10.1016/j.repc.2021.06.021
Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic José Silva-Cardoso, Emilia Moreira
10.1016/j.repc.2022.08.006
Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review Cândida Fonseca, Dulce Brito, Patrícia Branco, João Miguel Frazão, José Silva-Cardoso, Paulo Bettencourt
10.1016/j.repc.2020.03.015